Format
Sort by
Items per page

Send to

Choose Destination

Best matches for DESVENLAFAXINE/TU:

Search results

Items: 1 to 20 of 47

1.

Withdrawal-Emergent Dyskinesia Following Abrupt Discontinuation of Desvenlafaxine.

Wu L, Gerdts EA, Alam A.

Prim Care Companion CNS Disord. 2019 Jan 10;21(1). pii: 18l02362. doi: 10.4088/PCC.18l02362. No abstract available.

2.

Relationship between work functioning and self-reported cognitive complaints in patients with major depressive disorder treated with desvenlafaxine.

Alonso-Prieto E, Rubino C, Lucey M, Evans VC, Tam EM, Woo C, Iverson GL, Chakrabarty T, Yatham LN, Lam RW.

Psychiatry Res. 2019 Feb;272:144-148. doi: 10.1016/j.psychres.2018.12.062. Epub 2018 Dec 10.

PMID:
30583256
3.

Hyponatremia Associated With Tramadol in a Patient With Alcohol Use Disorder and Anxiety Taking Desvenlafaxine.

Garakani A.

Prim Care Companion CNS Disord. 2018 Dec 13;20(6). pii: 18l02316. doi: 10.4088/PCC.18l02316. No abstract available.

4.

Cognitive Deficits Following a Post-Myocardial Infarct in the Rat Are Blocked by the Serotonin-Norepinephrine Reuptake Inhibitor Desvenlafaxine.

Malick M, Gilbert K, Brouillette J, Godbout R, Rousseau G.

Int J Mol Sci. 2018 Nov 26;19(12). pii: E3748. doi: 10.3390/ijms19123748.

5.

Desvenlafaxine vs. placebo in the treatment of persistent depressive disorder.

Hellerstein DJ, Stewart JW, Chen Y, Arunagiri V, Peterson BS, McGrath PJ.

J Affect Disord. 2019 Feb 15;245:403-411. doi: 10.1016/j.jad.2018.11.065. Epub 2018 Nov 5.

PMID:
30423468
6.

Switch to a manic episode after desvenlafaxine discontinuation in bipolar disorder.

Muquebil Ali Al Shaban-Rodríguez OW, Álvarez de Morales E, Rodríguez-Turiel C, Fernández-Menéndez MA, García-Álvarez G.

Actas Esp Psiquiatr. 2018 Jul;46(4):156-8. Epub 2018 Jul 1. No abstract available.

7.

Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review.

Fava GA, Benasi G, Lucente M, Offidani E, Cosci F, Guidi J.

Psychother Psychosom. 2018;87(4):195-203. doi: 10.1159/000491524. Epub 2018 Jul 17. Review.

8.

Serum and Saliva Concentrations of Venlafaxine, O-Desmethylvenlafaxine, Quetiapine, and Citalopram in Psychiatric Patients.

Ebert K, Maurice E, Lukačin R, Fleischhaker C, Schulz E, Ebert D, Clement HW.

Ther Drug Monit. 2018 Jun;40(3):351-355. doi: 10.1097/FTD.0000000000000508.

PMID:
29746434
9.

A pilot, open-label, 8-week study evaluating desvenlafaxine for treatment of major depression in methadone-maintained individuals with opioid use disorder.

El Hage C, Ghabrash MF, Dubreucq S, Brissette S, Lespérance F, Lespérance P, Ouellet-Plamondon C, Bruneau J, Jutras-Aswad D.

Int Clin Psychopharmacol. 2018 Sep;33(5):268-273. doi: 10.1097/YIC.0000000000000223.

PMID:
29738425
10.

Neuroprotective evidence of alpha-lipoic acid and desvenlafaxine on memory deficit in a neuroendocrine model of depression.

de Sousa CNS, Meneses LN, Vasconcelos GS, da Silva Medeiros I, Silva MCC, Mouaffak F, Kebir O, da Silva Leite CMG, Patrocinio MCA, Macedo D, Vasconcelos SMM.

Naunyn Schmiedebergs Arch Pharmacol. 2018 Aug;391(8):803-817. doi: 10.1007/s00210-018-1509-1. Epub 2018 May 7.

PMID:
29732526
11.

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.

Welsch P, Üçeyler N, Klose P, Walitt B, Häuser W.

Cochrane Database Syst Rev. 2018 Feb 28;2:CD010292. doi: 10.1002/14651858.CD010292.pub2. Review.

12.

Population Pharmacokinetics of Desvenlafaxine: Pharmacokinetics in Korean Versus US Populations.

Nichols AI, Liao S, Abbas R.

Clin Pharmacol Drug Dev. 2018 May;7(4):441-450. doi: 10.1002/cpdd.419. Epub 2017 Dec 11.

PMID:
29228473
13.

Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder.

Weihs KL, Murphy W, Abbas R, Chiles D, England RD, Ramaker S, Wajsbrot DB.

J Child Adolesc Psychopharmacol. 2018 Feb;28(1):36-46. doi: 10.1089/cap.2017.0100. Epub 2017 Nov 30.

14.

Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder.

Atkinson S, Lubaczewski S, Ramaker S, England RD, Wajsbrot DB, Abbas R, Findling RL.

J Child Adolesc Psychopharmacol. 2018 Feb;28(1):55-65. doi: 10.1089/cap.2017.0099. Epub 2017 Nov 29.

15.

False-positive phencyclidine (PCP) on urine drug screen attributed to desvenlafaxine (Pristiq) use.

Farley TM, Anderson EN, Feller JN.

BMJ Case Rep. 2017 Nov 23;2017. pii: bcr-2017-222106. doi: 10.1136/bcr-2017-222106.

PMID:
29170178
16.

Antidepressant polypharmacy and the potential of pharmacokinetic interactions: Doxepin but not mirtazapine causes clinically relevant changes in venlafaxine metabolism.

Paulzen M, Haen E, Hiemke C, Fay B, Unholzer S, Gründer G, Schoretsanitis G.

J Affect Disord. 2018 Feb;227:506-511. doi: 10.1016/j.jad.2017.11.046. Epub 2017 Nov 13.

PMID:
29156365
17.

Takotsubo Cardiomyopathy and Intraoperative Cardiac Arrest: Is Desvenlafaxine a Contributing Factor?

Gurunathan U.

J Cardiothorac Vasc Anesth. 2018 Feb;32(1):e16-e18. doi: 10.1053/j.jvca.2017.08.031. Epub 2017 Aug 19. No abstract available.

PMID:
29153932
18.

Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder.

Katzman MA, Nierenberg AA, Wajsbrot DB, Meier E, Prieto R, Pappadopulos E, Mackell J, Boucher M.

J Clin Psychopharmacol. 2017 Oct;37(5):555-561. doi: 10.1097/JCP.0000000000000775.

19.

The impact of fatigue and energy on work functioning and impairment in patients with major depressive disorder treated with desvenlafaxine.

Sarfati D, Evans VC, Tam EM, Woo C, Iverson GL, Yatham LN, Lam RW.

Int Clin Psychopharmacol. 2017 Nov;32(6):343-349. doi: 10.1097/YIC.0000000000000192.

PMID:
28763344
20.

Effect of desvenlafaxine 50 mg and 100 mg on energy and lassitude in patients with major depressive disorder: A pooled analysis.

Lam RW, Wajsbrot DB, Meier E, Pappadopulos E, Mackell JA, Boucher M.

J Psychopharmacol. 2017 Sep;31(9):1204-1214. doi: 10.1177/0269881117719261. Epub 2017 Jul 18.

PMID:
28718346

Supplemental Content

Loading ...
Support Center